Case Study: Stage 4 Pancreatic Neuroendocrine Tumor, Poorly Differentiated, High-Grade Carcinoma, Small Cell Type

With the advanced-stage diagnosis of one of the rare forms of cancer, this patient was given only six weeks to live by conventional oncologists. He chose to refuse conventional treatments because of the poor chance of success and his apprehensions about the side effects of maximum therapeutic dose standard untargeted chemotherapy. Typically, neuroendocrine cancers do not respond well to conventional chemotherapy and radiation, but immunotherapy helps, which explains why he experienced exceptional results with Envita Medical Centers' unique approach!



